FoxM1-mediated RFC5 expression promotes temozolomide resistance

Volume: 33, Issue: 6, Pages: 527 - 537
Published: Feb 9, 2017
Abstract
Although methylguanine-DNA-methyltransferase (MGMT) plays an important role in resistance to temozolomide (TMZ) in glioma, 40% of gliomas with MGMT inactivation are still resistant to TMZ. The underlying mechanism is not clear. Here, we report that forkhead box M1 (FoxM1) transcriptionally activates the expression of DNA repair gene replication factor C5 (RFC5) to promote TMZ resistance in glioma cells independent of MGMT activation. We showed...
Paper Details
Title
FoxM1-mediated RFC5 expression promotes temozolomide resistance
Published Date
Feb 9, 2017
Volume
33
Issue
6
Pages
527 - 537
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.